中国欠发达地区西部地区慢性乙型肝炎患者的多模式治疗和20

StephenW

BMC Infect Dis. 2019 Jan 14;19(1):49. doi: 10.1186/s12879-019-3673-4.
Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature.
Zhang YR1, Wu DM2, Liu XC2, Zhou N3, Cao CC4, Liu WH5, Wang CX6, Wang H3.
Author information

1
    Department of Infectious diseases, The First People's Hospital of Lanzhou, No. 1 of Wu jia yuan West Street, Qilihe District, Lanzhou, 730050, Gansu, China. [email protected].
2
    Department of Gastroenterology, The First People's Hospital of Lanzhou, Gansu, 730050, China.
3
    Department of Infectious diseases, The First People's Hospital of Lanzhou, No. 1 of Wu jia yuan West Street, Qilihe District, Lanzhou, 730050, Gansu, China.
4
    Department of Radiology, The First People's Hospital of Lanzhou, Gansu, 730050, China.
5
    Department of general surgery, The First People's Hospital of Lanzhou, Gansu, 730050, China.
6
    Department of laboratory, The First People's Hospital of Lanzhou, Gansu, 730050, China.

Abstract
BACKGROUND:

For patients with chronic hepatitis B and cirrhosis in less developed western regions in China, due to constraints of local economic conditions, the choice of treatment measures is often limited. However if patients recieved valid management and effective treatment, they were able to maintain their health and benign prognosis.
CASE PRESENTATION:

This study narrates the long-term treatment and careful follow-up of a patient with chronic hepatitis B and cirrhosis in a less developed western region in China, and analyzes the prognosis of the disease and countermeasures.
CONCLUSIONS:

This would partly reflect the development of antiviral therapy for chronic hepatitis B and multidisciplinary comprehensive treatment for cirrhosis-related complications in remote region with limited resources in the past 20 years.
KEYWORDS:

Cirrhosis; Disease management; Hepatitis B; Multimodal therapy

PMID:
    30642253
DOI:
    10.1186/s12879-019-3673-4

StephenW

BMC Infect Dis。 2019年1月14日; 19（1）：49。 doi：10.1186 / s12879-019-3673-4。
中国欠发达地区西部地区慢性乙型肝炎患者的多模式治疗和20年有效管理 - 病例报告和文献复习。
Zhang YR1，Wu DM2，Liu XC2，Zhou N3，Cao CC4，Liu WH5，Wang CX6，Wang H3。
作者信息

1
    兰州市第三人民医院传染病科，甘肃省七里河区吴家园西街1号，甘肃兰州730050 [email protected]。
2
    甘肃兰州市第一人民医院消化内科，甘肃730050
3
    兰州市第三人民医院传染病科，甘肃省七里河区吴家园西街1号，甘肃兰州730050
4
    甘肃兰州市第一人民医院放射科，730050
五
    甘肃兰州市第一人民医院普外科，甘肃730050
6
    甘肃兰州市第一人民医院实验室，甘肃730050

抽象
背景：

对于中国西部欠发达地区慢性乙型肝炎和肝硬化患者，由于当地经济条件的限制，治疗措施的选择往往有限。然而，如果患者接受了有效的管理和有效的治疗，他们就能够保持健康和良性预后。
案例介绍：

本研究叙述了中国西部欠发达地区慢性乙型肝炎和肝硬化患者的长期治疗和认真随访，分析了该病的预后和对策。
结论：

这部分反映了过去20年来资源有限的偏远地区肝硬化相关并发症的慢性乙型肝炎抗病毒治疗和多学科综合治疗的发展。
关键词：

肝硬化;疾病管理;乙型肝炎;多模式治疗

结论：
    30642253
DOI：
    10.1186 / s12879-019-3673-4

StephenW

https://bmcinfectdis.biomedcentr ... 6/s12879-019-3673-4